REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $477,542 | -53.0% | 41,634 | +3.7% | 0.00% | -50.0% |
| Q2 2023 | $1,016,298 | -19.0% | 40,154 | +3.0% | 0.01% | -25.0% |
| Q1 2023 | $1,255,127 | +78.0% | 38,967 | +2.0% | 0.01% | +60.0% |
| Q4 2022 | $705,024 | -23.4% | 38,192 | +12.1% | 0.01% | -28.6% |
| Q3 2022 | $920,000 | +103.1% | 34,060 | +3.8% | 0.01% | +133.3% |
| Q2 2022 | $453,000 | -33.4% | 32,810 | -5.9% | 0.00% | -25.0% |
| Q1 2022 | $680,000 | +11.7% | 34,851 | -6.6% | 0.00% | +33.3% |
| Q4 2021 | $609,000 | -43.1% | 37,304 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $1,070,000 | -8.2% | 38,420 | -2.3% | 0.01% | +50.0% |
| Q2 2021 | $1,166,000 | +13.8% | 39,333 | +7.2% | 0.00% | 0.0% |
| Q1 2021 | $1,025,000 | -1.2% | 36,677 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $1,037,000 | +9.6% | 36,580 | -2.8% | 0.00% | -20.0% |
| Q3 2020 | $946,000 | +11.6% | 37,630 | +8.3% | 0.01% | +25.0% |
| Q2 2020 | $848,000 | +87.6% | 34,732 | +13.7% | 0.00% | +100.0% |
| Q1 2020 | $452,000 | -1.5% | 30,556 | +8.1% | 0.00% | 0.0% |
| Q4 2019 | $459,000 | +27.1% | 28,263 | +1.6% | 0.00% | +100.0% |
| Q3 2019 | $361,000 | -0.6% | 27,806 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $363,000 | -5.5% | 28,000 | +14.8% | 0.00% | 0.0% |
| Q1 2019 | $384,000 | -11.7% | 24,391 | +12.9% | 0.00% | -50.0% |
| Q4 2018 | $435,000 | -19.6% | 21,605 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $541,000 | -7.8% | 21,771 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $587,000 | +10.8% | 21,378 | +24.3% | 0.00% | 0.0% |
| Q1 2018 | $530,000 | -4.0% | 17,205 | +11.4% | 0.00% | 0.0% |
| Q4 2017 | $552,000 | +33.3% | 15,440 | +2.7% | 0.00% | +100.0% |
| Q3 2017 | $414,000 | +12.8% | 15,038 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $367,000 | +40.1% | 13,914 | +10.5% | 0.00% | 0.0% |
| Q1 2017 | $262,000 | +7.8% | 12,590 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $243,000 | -99.9% | 11,756 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $191,067,000 | +19.4% | 11,787 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $160,058,000 | -13.5% | 11,769 | +10.9% | 0.00% | 0.0% |
| Q1 2016 | $185,000,000 | -40.9% | 10,608 | +15.8% | 0.00% | 0.0% |
| Q4 2015 | $313,000,000 | +108204.5% | 9,164 | -5.8% | 0.00% | 0.0% |
| Q3 2015 | $289,000 | -99.9% | 9,725 | +6.1% | 0.00% | 0.0% |
| Q2 2015 | $293,225,000 | +161.6% | 9,169 | +69.5% | 0.00% | – |
| Q1 2015 | $112,108,000 | +22.4% | 5,408 | 0.0% | 0.00% | – |
| Q4 2014 | $91,612,000 | +4.3% | 5,408 | +19.0% | 0.00% | – |
| Q3 2014 | $87,874,000 | -42.9% | 4,546 | +0.5% | 0.00% | -100.0% |
| Q2 2014 | $153,816,000 | – | 4,524 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |